Implantable Neurostimulation Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publication Month: Nov 2020 | No. of Pages: 98 Published By: 99Strategy
Single User License: US $ 2800
Corporate User License: US $ 5600

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Implantable Neurostimulation Devices market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Implantable Neurostimulation Devices market segmented into
Pain Management
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others

Based on the end-use, the global Implantable Neurostimulation Devices market classified into
Pain Management
Parkinson's Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Others

Based on geography, the global Implantable Neurostimulation Devices market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IMPLANTABLE NEUROSTIMULATION DEVICES INDUSTRY
2.1 Summary about Implantable Neurostimulation Devices Industry
2.2 Implantable Neurostimulation Devices Market Trends
2.2.1 Implantable Neurostimulation Devices Production & Consumption Trends
2.2.2 Implantable Neurostimulation Devices Demand Structure Trends
2.3 Implantable Neurostimulation Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Spinal Cord Stimulation (SCS)
4.2.2 Gastric Electric Stimulation (GES)
4.2.3 Deep Brain Stimulation (DBS)
4.2.4 Sacral Nerve Stimulation (SNS)
4.2.5 Vagus Nerve Stimulation (VNS)
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pain Management
4.3.2 Parkinson's Disease
4.3.3 Urinary and Fecal Incontinence
4.3.4 Epilepsy
4.3.5 Gastroparesis
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Spinal Cord Stimulation (SCS)
5.2.2 Gastric Electric Stimulation (GES)
5.2.3 Deep Brain Stimulation (DBS)
5.2.4 Sacral Nerve Stimulation (SNS)
5.2.5 Vagus Nerve Stimulation (VNS)
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pain Management
5.3.2 Parkinson's Disease
5.3.3 Urinary and Fecal Incontinence
5.3.4 Epilepsy
5.3.5 Gastroparesis
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Gastric Electric Stimulation (GES)
6.2.3 Deep Brain Stimulation (DBS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Vagus Nerve Stimulation (VNS)
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pain Management
6.3.2 Parkinson's Disease
6.3.3 Urinary and Fecal Incontinence
6.3.4 Epilepsy
6.3.5 Gastroparesis
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Spinal Cord Stimulation (SCS)
7.2.2 Gastric Electric Stimulation (GES)
7.2.3 Deep Brain Stimulation (DBS)
7.2.4 Sacral Nerve Stimulation (SNS)
7.2.5 Vagus Nerve Stimulation (VNS)
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pain Management
7.3.2 Parkinson's Disease
7.3.3 Urinary and Fecal Incontinence
7.3.4 Epilepsy
7.3.5 Gastroparesis
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Spinal Cord Stimulation (SCS)
8.2.2 Gastric Electric Stimulation (GES)
8.2.3 Deep Brain Stimulation (DBS)
8.2.4 Sacral Nerve Stimulation (SNS)
8.2.5 Vagus Nerve Stimulation (VNS)
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pain Management
8.3.2 Parkinson's Disease
8.3.3 Urinary and Fecal Incontinence
8.3.4 Epilepsy
8.3.5 Gastroparesis
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Spinal Cord Stimulation (SCS)
9.2.2 Gastric Electric Stimulation (GES)
9.2.3 Deep Brain Stimulation (DBS)
9.2.4 Sacral Nerve Stimulation (SNS)
9.2.5 Vagus Nerve Stimulation (VNS)
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pain Management
9.3.2 Parkinson's Disease
9.3.3 Urinary and Fecal Incontinence
9.3.4 Epilepsy
9.3.5 Gastroparesis
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medtronic
10.1.2 Boston Scientific
10.1.3 St. Jude Medical (Abbott)
10.1.4 LivaNova
10.1.5 Nevro
10.1.6 NeuroPace
10.1.7 Beijing Pins
10.1.8 Synapse Biomedical
10.2 Implantable Neurostimulation Devices Sales Date of Major Players (2017-2020e)
10.2.1 Medtronic
10.2.2 Boston Scientific
10.2.3 St. Jude Medical (Abbott)
10.2.4 LivaNova
10.2.5 Nevro
10.2.6 NeuroPace
10.2.7 Beijing Pins
10.2.8 Synapse Biomedical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

Tables and Figures

List of Table
1.Table Implantable Neurostimulation Devices Product Type Overview
2.Table Implantable Neurostimulation Devices Product Type Market Share List
3.Table Implantable Neurostimulation Devices Product Type of Major Players
4.Table Brief Introduction of Medtronic
5.Table Brief Introduction of Boston Scientific
6.Table Brief Introduction of St. Jude Medical (Abbott)
7.Table Brief Introduction of LivaNova
8.Table Brief Introduction of Nevro
9.Table Brief Introduction of NeuroPace
10.Table Brief Introduction of Beijing Pins
11.Table Brief Introduction of Synapse Biomedical
12.Table Products & Services of Medtronic
13.Table Products & Services of Boston Scientific
14.Table Products & Services of St. Jude Medical (Abbott)
15.Table Products & Services of LivaNova
16.Table Products & Services of Nevro
17.Table Products & Services of NeuroPace
18.Table Products & Services of Beijing Pins
19.Table Products & Services of Synapse Biomedical
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Implantable Neurostimulation Devices Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Implantable Neurostimulation Devices Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Implantable Neurostimulation Devices Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Implantable Neurostimulation Devices Market Forecast (Million USD) Share by Demand 2021f-2026f



List Of Figures
List of Figure
1.Figure Global Implantable Neurostimulation Devices Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Implantable Neurostimulation Devices Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Implantable Neurostimulation Devices Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Implantable Neurostimulation Devices Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Implantable Neurostimulation Devices Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Implantable Neurostimulation Devices Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Implantable Neurostimulation Devices Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Parkinson's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Urinary and Fecal Incontinence Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Epilepsy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Gastroparesis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Spinal Cord Stimulation (SCS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Gastric Electric Stimulation (GES) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Deep Brain Stimulation (DBS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Sacral Nerve Stimulation (SNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Vagus Nerve Stimulation (VNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Pain Manage

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets